2024
A trial of implementation facilitation to increase timely admission to methadone treatment
Gryczynski J, Mitchell S, Whitter M, Fuller D, Mitchell M, Edelman E, Schwartz R. A trial of implementation facilitation to increase timely admission to methadone treatment. Journal Of Substance Use And Addiction Treatment 2024, 162: 209375. PMID: 38642889, PMCID: PMC11197887, DOI: 10.1016/j.josat.2024.209375.Peer-Reviewed Original ResearchConceptsOpioid treatment programsInterim methadonePre-implementationAdmissions to methadone treatmentImplementation facilitatorsLocal championsMethadone treatmentPre-implementation phaseAcademic detailingLearning CollaborativeExternal facilitationData collectionStudy launchWedge designTreatment programs
2023
Building medication for opioid use disorder prescriber capacity during the opioid epidemic: Prescriber recruitment trends and methods
Molfenter T, Jacobson N, Kim J, Horst J, Kim H, Madden L, Brown R, Haram E, Knudsen H. Building medication for opioid use disorder prescriber capacity during the opioid epidemic: Prescriber recruitment trends and methods. Journal Of Substance Use And Addiction Treatment 2023, 147: 208975. PMID: 36804353, PMCID: PMC10833474, DOI: 10.1016/j.josat.2023.208975.Peer-Reviewed Original ResearchConceptsRecruitment strategiesAdvanced nurse practitionersSUD treatment servicesSUD clinicsPhysician prescribersOpioid epidemicPhysician recruitmentNurse practitionersTreatment servicesPhysician assistantsPatient carePrescribing capacityPrescribersStudy settingClinical resourcesDisorder settingsStudy periodPhysiciansTreatment sitesYear 3Dedicated budgetIndividual factorsBuprenorphineMedicationsClinic
2022
Social and Behavioral Sciences: Response to the Opioid and Pain Crises in the United States
Kerns RD. Social and Behavioral Sciences: Response to the Opioid and Pain Crises in the United States. American Journal Of Public Health 2022, 112: s6-s8. PMID: 35143280, PMCID: PMC8842200, DOI: 10.2105/ajph.2022.306773.Peer-Reviewed Original Research
2021
Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study
Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study. The Lancet Public Health 2021, 7: e56-e64. PMID: 34861189, PMCID: PMC8756295, DOI: 10.1016/s2468-2667(21)00248-6.Peer-Reviewed Original ResearchConceptsOpioid use disorderAddiction consult serviceHospital-based strategiesUS opioid epidemicOpioid epidemicUse disordersConsult serviceProbabilistic sensitivity analysesClinical impactDrug useIncremental cost-effectiveness ratioInjection-related infectionsInjection drug useMean lifetime costsNational InstituteCost-effectiveness ratioHarm reduction servicesDeterministic sensitivity analysesInpatient prescribingObservational cohortRecurrent infectionsOutpatient treatmentClinical trialsOverdose riskMedicationsLetter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?
De Aquino JP, Bahji A, D'Souza DC. Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again? Cannabis And Cannabinoid Research 2021, 7: 898-900. PMID: 34714101, PMCID: PMC9784580, DOI: 10.1089/can.2021.0155.Peer-Reviewed Original ResearchBlack Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic
Essien UR, Ifidon A, Sue KL. Black Pain Matters: Prioritizing Antiracism and Equity in the Opioid Epidemic. Journal Of Hospital Medicine 2021, 16: 638-639. PMID: 34613902, PMCID: PMC8494278, DOI: 10.12788/jhm.3703.Commentaries, Editorials and LettersRemoving One Barrier to Opioid Use Disorder Treatment
Weimer MB, Wakeman SE, Saitz R. Removing One Barrier to Opioid Use Disorder Treatment. JAMA 2021, 325: 1147-1148. PMID: 33630020, DOI: 10.1001/jama.2021.0958.Commentaries, Editorials and LettersThe opioid crisis and HIV in the USA: deadly synergies
Hodder SL, Feinberg J, Strathdee SA, Shoptaw S, Altice FL, Ortenzio L, Beyrer C. The opioid crisis and HIV in the USA: deadly synergies. The Lancet 2021, 397: 1139-1150. PMID: 33617769, DOI: 10.1016/s0140-6736(21)00391-3.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnalgesics, OpioidBlack or African AmericanCase-Control StudiesDisease OutbreaksEvidence-Based MedicineFemaleFentanylHealth Services AccessibilityHispanic or LatinoHIV InfectionsHumansMaleNeedle SharingOpiate OverdoseOpioid EpidemicOpioid-Related DisordersSocial StigmaUnited StatesWhite PeopleYoung AdultConceptsNew HIV diagnosesHIV diagnosisOpioid epidemicHIV preventionMultiple evidence-based interventionsGreat public health problemRecent HIV outbreaksOpioid overdose death ratesOpioid use disorderLarge central metropolitan areasPublic health problemOverdose death ratesComprehensive health careEvidence-based interventionsDeadly synergyHIV acquisitionSynthetic opioid fentanylSyringe sharingHIV outbreakUse disordersOpioid fentanylTreatment servicesHealth problemsOpioid crisisDeath rate
2020
COVID-19 Has Provided 20/20 Vision Illuminating Our Nation’s Health Crises
Katzman J, Katzman J. COVID-19 Has Provided 20/20 Vision Illuminating Our Nation’s Health Crises. Pain Medicine 2020, 22: 6-9. PMID: 32986827, PMCID: PMC7543634, DOI: 10.1093/pm/pnaa357.Peer-Reviewed Original ResearchFederal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda
Springer SA, Barocas J, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda. The Journal Of Infectious Diseases 2020, 222: s230-s238. PMID: 32877568, PMCID: PMC7467230, DOI: 10.1093/infdis/jiz673.Peer-Reviewed Original ResearchMeSH KeywordsBacteremiaCommunicable Disease ControlFederal GovernmentHealth PolicyHepatitis BHepatitis CHIV InfectionsHuman RightsHumansIllicit DrugsInfectious Disease MedicineIntersectoral CollaborationInvasive Fungal InfectionsOpioid EpidemicPatient AdvocacyPreventive Health ServicesPublic Health AdministrationSocieties, MedicalState GovernmentSubstance-Related DisordersUnited StatesConceptsIllicit drug useInfectious diseasesAddiction specialistsDrug useSubstance use disorder treatmentUse disorder treatmentHarm reduction toolHIV physiciansInfectious complicationsEvidence-based practiceHIV epidemicOpioid epidemicCare continuumAssociated InfectionsTreatment servicesDisorder treatmentOpioid crisisDiseaseIDSAReview programEpidemicFurther disseminationHuman rights-based responseAdvocacy agendaMorbidityAddressing the Intersection of Infectious Disease Epidemics and Opioid and Substance Use Epidemics
Springer SA, del Rio C. Addressing the Intersection of Infectious Disease Epidemics and Opioid and Substance Use Epidemics. Infectious Disease Clinics Of North America 2020, 34: xiii-xiv. PMID: 32782107, PMCID: PMC7414777, DOI: 10.1016/j.idc.2020.06.016.Peer-Reviewed Original ResearchLessons Learned from the Response to the Human Immunodeficiency Virus Epidemic that Can Inform Addressing the Opioid Epidemic
Springer SA, del Rio C. Lessons Learned from the Response to the Human Immunodeficiency Virus Epidemic that Can Inform Addressing the Opioid Epidemic. Infectious Disease Clinics Of North America 2020, 34: 637-647. PMID: 32782106, PMCID: PMC7414693, DOI: 10.1016/j.idc.2020.06.015.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidHIV InfectionsHumansOpioid EpidemicOpioid-Related DisordersUnited StatesHepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study
Assoumou S, Nolen S, Hagan L, Wang J, Eftekhari Yazdi G, Thompson W, Mayer K, Puro J, Zhu L, Salomon J, Linas B. Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study. The American Journal Of Medicine 2020, 133: e641-e658. PMID: 32603791, PMCID: PMC8041089, DOI: 10.1016/j.amjmed.2020.05.029.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntiviral AgentsCommunity Health CentersCost-Benefit AnalysisCounselorsFemaleHepatitis C AntibodiesHepatitis C, ChronicHumansLife ExpectancyLiver CirrhosisMaleMass ScreeningMiddle AgedOpioid EpidemicOregonPoint-of-Care TestingQuality-Adjusted Life YearsRNA, ViralSerologic TestsUnited StatesUnited States Health Resources and Services AdministrationConceptsQuality-adjusted life yearsFederally Qualified Health CentersHepatitis C virusRNA testingOpioid epidemicQualified health centersAnti-HCV test resultsKnowledge of antibody statusProportion of patientsIncremental cost-effectiveness ratioAnti-HCV testHepatitis C casesCost-effectiveness ratioHepatitis C diseaseHepatitis C testingHepatitis C managementHealth centersClinical outcomesAntibody statusC virusCost-effectiveness studiesCirrhosis casesRapid testC diseaseC casesBarriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
Hawk KF, D’Onofrio G, Chawarski MC, O’Connor P, Cowan E, Lyons MS, Richardson L, Rothman RE, Whiteside LK, Owens PH, Martel SH, Coupet E, Pantalon M, Curry L, Fiellin DA, Edelman EJ. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine. JAMA Network Open 2020, 3: e204561. PMID: 32391893, PMCID: PMC7215257, DOI: 10.1001/jamanetworkopen.2020.4561.Peer-Reviewed Original ResearchConceptsOpioid use disorderEmergency departmentAdvanced practice cliniciansED cliniciansClinicians' readinessOngoing treatmentTreatment of OUDEmergency department-initiated buprenorphineUntreated opioid use disorderDrug Addiction Treatment ActDecrease opioid useVisual analog scaleHealth Services frameworkAcademic emergency departmentMixed-methods formative evaluationQuality of careSubset of participantsBuprenorphine initiationClinician typeOpioid useED patientsAnalog scaleOngoing careDepartmental protocolPractice cliniciansWhen Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis
Becker WC, Fiellin DA. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Annals Of Internal Medicine 2020, 173: m20-1210. PMID: 32240291, PMCID: PMC7138333, DOI: 10.7326/m20-1210.Peer-Reviewed Original ResearchHCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic
Assoumou S, Wang J, Nolen S, Eftekhari Yazdi G, Mayer K, Puro J, Salomon J, Linas B. HCV Testing and Treatment in a National Sample of US Federally Qualified Health Centers during the Opioid Epidemic. Journal Of General Internal Medicine 2020, 35: 1477-1483. PMID: 32133577, PMCID: PMC7210368, DOI: 10.1007/s11606-020-05701-9.Peer-Reviewed Original ResearchConceptsSustained virological responseHepatitis C virusIdentified OUDOpioid use disorderChronic hepatitis C virusTreatment initiationFactors associated with treatment initiationHepatitis C virus RNA testingDiagnosis of opioid use disorderTreat hepatitis C virusReal-world cohortHepatitis C virus testingTreatment initiation ratesQualified health centersAssociated with higher oddsVirological responseInitial treatmentRNA testingMultivariable adjustmentC virusCohort studyTreatment outcomesHCV managementHealth centersImprove outcomesA Call to Action to Combat the Opioid Epidemic Among Women.
Springer SA, Biondi BE, Frank C, El-Bassel N. A Call to Action to Combat the Opioid Epidemic Among Women. Journal Of Addiction Medicine 2020, 14: 364-366. PMID: 32011410, PMCID: PMC7392801, DOI: 10.1097/adm.0000000000000622.Peer-Reviewed Original Research
2019
Patients With Opioid Use Disorder Deserve Trained Providers.
Weimer MB, Tetrault JM, Fiellin DA. Patients With Opioid Use Disorder Deserve Trained Providers. Annals Of Internal Medicine 2019, 171: 931-932. PMID: 31766053, DOI: 10.7326/m19-2303.Commentaries, Editorials and LettersBuprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States?
Rhee TG, Rosenheck RA. Buprenorphine prescribing for opioid use disorder in medical practices: can office‐based out‐patient care address the opiate crisis in the United States? Addiction 2019, 114: 1992-1999. PMID: 31307111, PMCID: PMC6800773, DOI: 10.1111/add.14733.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmbulatory CareBlack or African AmericanBuprenorphineBuprenorphine, Naloxone Drug CombinationDelivery of Health CareFemaleHealthcare DisparitiesHispanic or LatinoHumansInsurance, HealthMaleMedicaidMental DisordersMiddle AgedNarcotic AntagonistsOpiate Substitution TreatmentOpioid EpidemicOpioid-Related DisordersPractice Patterns, Physicians'United StatesWhite PeopleYoung AdultConceptsDiagnosis of OUDOpioid use disorderOffice-based medical practiceUse disordersBuprenorphine prescriptionsNational Ambulatory Medical Care SurveyAmbulatory Medical Care SurveyMedical practiceSerious public health issueSubstance use disordersPublic health issueRepeated cross-sectional designAdult patientsBuprenorphine prescribingOUD diagnosisPhysician visitsCross-sectional designMedicaid insuranceCare SurveyCare addressesPsychiatric disordersBuprenorphineOpiate crisisHealth issuesDiagnosisA Review of Adjunctive Therapies for Burn Injury Pain During the Opioid Crisis
Kim D, Pruskowski K, Ainsworth C, Linsenbardt H, Rizzo J, Cancio L. A Review of Adjunctive Therapies for Burn Injury Pain During the Opioid Crisis. Journal Of Burn Care & Research 2019, 40: 983-995. PMID: 31259369, DOI: 10.1093/jbcr/irz111.Peer-Reviewed Original ResearchConceptsPain management therapiesManagement therapyAdjunctive therapyOpioid usePain severityPain managementSystematic reviewBurn injury painUse of opioidsPain management strategiesAnalgesic regimensOpioid consumptionOpioid overuseBackground painIntravenous narcoticsCohort studyInjury painCrossover trialProspective studyHistorical controlsOpioid crisisTherapyOpioidsTrialsNationwide shortage
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply